KRAS and pancreatic neoplasm: Among the remaining 3 pancreatic cancer patients with discordant KRAS mutation status, two patients had the KRAS mutations (1 G12D, 1 G12R) detected in plasma samples but not detected in tissue samples, which may result from the tissue heterogeneity.